Sentara Heart’s 7th Annual PAH Symposium

Image Heart Hands Image Heart Hands Image Heart Hands



Registration Required

A Guide for the Journey:
Current Insights into the Diagnosis and Management of Pulmonary Hypertension

Sentara Heart’s Annual PAH Symposium offers a comprehensive survey of current knowledge in the field of pulmonary hypertension. The sessions will increase attendee knowledge about diagnosis and management of this complex disease. Attendees will be better prepared to screen for and detect pulmonary hypertension early, facilitating prompt referral to programs for comprehensive management. This year’s conference will offer opportunities to interact with prominent faculty on practical issues, including management of PH attributable to parenchymal lung disease and the PAH patient with sepsis or need for surgery. Breaking information on disease pathogenesis, risk assessment, and directed therapy will be presented. The symposium is designed for physicians in internal medicine, pulmonary medicine, cardiology, critical care, and family practice. It will also be of interest to respiratory therapists, nurse practitioners, physician assistants, nurses, and other health professional caring for patients with pulmonary disease.

Saturday November 10, 2018 / 8am-4pm Hilton Norfolk The MAIN

Course Director: Michael S. Eggert, MD, FCCP

Medial Director, Pulmonary Arterial Hypertension Program, Sentara Heart Hospital

Co-Course Director: Joshua Sill, MD, FACP, FCCP

Program Director, Pulmonary and Critical Care Fellowship, EVMS

Target Audience: Designed for physicians in the medical specialties of pulmonary medicine, critical care, infectious disease, internal medicine and family practice. It will also be of interest to respiratory care practitioners, physician assistants, nurse practitioners, nurses and other allied health care professionals interested in pulmonary medicine.

Course Objectives:
After completing this activity, participants should be better able to:

  • Identify signs, symptoms and risk factors associated with PAH to facilitate timely referral of patients.
  • Describe diagnostic tests used to identify patients with PAH.
  • Implement a more rapid and multidisciplinary approach to earlier detection of PAH.
  • Describe the pharmacologic management of PAH patients.
  • Discuss future advancement of care in pulmonary hypertension.


Sentara Healthcare is accredited by the Medical Society of Virginia (MSV) to provide continuing medical education for the physicians.

Credit Designation

Sentara Healthcare designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Virginia Board of Medicine

Physicians may claim up to 6.50 in Type 1 or Type 2 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for the renewal of an active medical license.

ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.